Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)

Turkey flag Turkey · Delayed Price · Currency is TRY
175.60
+4.70 (2.75%)
At close: Sep 26, 2025
2.75%
Market Cap52.68B
Revenue (ttm)14.32B
Net Income (ttm)573.84M
Shares Out300.00M
EPS (ttm)1.91
PE Ratio91.80
Forward PEn/a
Dividend1.11 (0.63%)
Ex-Dividend DateAug 12, 2025
Volume1,087,933
Average Volume867,681
Open170.90
Previous Close170.90
Day's Range170.00 - 176.80
52-Week Range79.95 - 216.00
Beta1.05
RSI49.36
Earnings DateNov 6, 2025

About IST:GENIL

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1... [Read more]

Sector Healthcare
Founded 1997
Employees 619
Stock Exchange Istanbul Stock Exchange
Ticker Symbol GENIL
Full Company Profile

Financial Performance

In 2024, IST:GENIL's revenue was 14.74 billion, an increase of 25.25% compared to the previous year's 11.77 billion. Earnings were 148.68 million, a decrease of -77.35%.

Financial Statements

News

There is no news available yet.